Depression and Anxiety Trial, Recruiting NCT06450704 Sponsor: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06450704
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Major Depressive Disorder (MDD) based on standard medical guidelines (confirmed through a structured interview).
  • Your depression is rated as at least "moderate" based on a standard depression scoring tool called the Hamilton Depression Rating Scale (a score of 14 or above).
  • You are receiving your care as an outpatient (meaning you are not staying overnight in a hospital).
  • You are currently taking antidepressant medication and are willing to continue taking it throughout the 12-week exercise programme.

Who may not be able to join:

  • You have been diagnosed with another major mental health condition in addition to depression (confirm with trial site).
  • You have any reason why you cannot safely have an MRI scan (for example, metal implants or a pacemaker).
  • You have taken anti-inflammatory medications or antibiotics in the week before joining the trial.
  • You have received any vaccines in the month before joining the trial.
  • You currently have a fever above 38°C (100.4°F) at the time of joining the trial.
  • You are pregnant.
  • You have a current problem with alcohol or drug misuse.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pilar López García, PhD, Universidad Autonoma de Madrid

Phone: (+34) 633467602

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Registry
ClinicalTrials.gov
Start date
21 April 2025
Est. completion
1 September 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Inflammatory and oxidative stress biomarkers; Brain imaging; Clinical evaluation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov